Passariello, M.; Camorani, S.; Vetrei, C.; Ricci, S.; Cerchia, L.; De Lorenzo, C.
Ipilimumab and Its Derived EGFR Aptamer-Based Conjugate Induce Efficient NK Cell Activation against Cancer Cells. Cancers 2020, 12, 331.
https://doi.org/10.3390/cancers12020331
AMA Style
Passariello M, Camorani S, Vetrei C, Ricci S, Cerchia L, De Lorenzo C.
Ipilimumab and Its Derived EGFR Aptamer-Based Conjugate Induce Efficient NK Cell Activation against Cancer Cells. Cancers. 2020; 12(2):331.
https://doi.org/10.3390/cancers12020331
Chicago/Turabian Style
Passariello, Margherita, Simona Camorani, Cinzia Vetrei, Stefania Ricci, Laura Cerchia, and Claudia De Lorenzo.
2020. "Ipilimumab and Its Derived EGFR Aptamer-Based Conjugate Induce Efficient NK Cell Activation against Cancer Cells" Cancers 12, no. 2: 331.
https://doi.org/10.3390/cancers12020331
APA Style
Passariello, M., Camorani, S., Vetrei, C., Ricci, S., Cerchia, L., & De Lorenzo, C.
(2020). Ipilimumab and Its Derived EGFR Aptamer-Based Conjugate Induce Efficient NK Cell Activation against Cancer Cells. Cancers, 12(2), 331.
https://doi.org/10.3390/cancers12020331